Prevalence and timing of authorized generics in the US market

A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding. The article sheds…

The post Prevalence and timing of authorized generics in the US market appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.